Different amounts of moderate to vigorous physical activity and change in glycemic variability in adolescents with type 1 diabetes: is there dose-response relationship?
AUTOR(ES)
Rebesco, Denise Barth; França, Suzana Nesi; Lima, Valderi Abreu de; Leite, Neiva; Smouter, Leandro; Souza, William Cordeiro de; Komatsu, William Ricardo; Mascarenhas, Luis Paulo Gomes
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
2020-06
RESUMO
ABSTRACT Objective To identify the level of physical activity and glycemic variability of adolescents with type 1 diabetes mellitus and to compare glycemic variability on days with different amounts of moderate to vigorous physical activity (MVPA). Subjects and methods A sample of 34 subjects aged 10 to 15 years, 18 (52.94%) female; age: 13.04 ± 1.94; HbA1c: 9.76 ± 1.51. Physical activity was measured by wGT3X accelerometer. The glucose data were obtained using continuous glucose monitoring, and the following glycemic variability measures were calculated: standard deviation (SD), low blood glucose index (LBGI), high blood glucose index (HBGI), mean amplitude of glycemic excursions (MAGE), glycemic risk assessment in diabetes equation (GRADE) and coefficient of variation (CV). The most and least active days (the days with greater and lesser time dedicated to physical activities of moderate to vigorous intensity, respectively) were identified. In addition, based on the whole period of accelerometer use, daily means of time spent in MVPA were identified among participants, who were then divided into three groups: up to 100 minutes; from 101 to 200 minutes and above 201 minutes. Then, the measures of glycemic variability were compared among the most and least active days and among the groups too. Results The amount of MVPA was significantly different between the days evaluated (237.49 ± 93.29 vs. 125.21 ± 58.10 minutes), but glycemic variability measures did not present a significant difference. Conclusion Despite the significant differences in the amount of MVPA between the two days evaluated, the glycemic variability did not change significantly. Arch Endocrinol Metab. 2020;64(3):312-8
Documentos Relacionados
- Enterovirus infections and type 1 diabetes mellitus: is there any relationship?
- Oral Artesunate Dose-Response Relationship in Acute Falciparum Malaria
- Dose-Response relationship of luteinizing hormone to luteinizing hormone—releasing hormone in man
- Dose-response in case-control studies.
- Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis